Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

USFDA inspection: Alembic Pharma gets 2 observations for Karkhadi facility

Ruchika Sharma25 March 2023 11:15 AM IST

Vadodara: Drugmaker, Alembic Pharmaceuticals, has announced that the US Food and Drug Administration (USFDA) has issued a Form 483 with two minor...

E-pharmacy Company features on Shark Tank India, Program, Sony TV get legal notice for violation of Drugs and Cosmetics Act

Ruchika Sharma24 March 2023 4:00 PM IST

The drugs and medicines supplied through Pharmallama without their original packaging would amount to supplying misbranded, adulterated or spurious...

Zydus Lifesciences wins USFDA approval for Lubiprostone Capsules to treat constipation

Ruchika Sharma24 March 2023 3:00 PM IST

The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, India.

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Lupin gets USFDA nod for primary biliary cholangitis drug Obeticholic Acid

Ruchika Sharma24 March 2023 2:00 PM IST

Mumbai: Global pharma major, Lupin Limited, has announced that the company has received tentative approval from the United States Food and Drug...

More deaths, injuries linked to recalled eyedrops

Ruchika Sharma24 March 2023 12:30 PM IST

Washington: US officials are reporting two more deaths and additional cases of vision loss linked to eyedrops tainted with a drug-resistant...

Zydus Lifesciences Depression drug Doxepin Hydrochloride bags USFDA okay

Ruchika Sharma24 March 2023 11:24 AM IST

The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad, India.

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Novo Nordisk, Dewpoint Therapeutics collaborate to explore field of biomolecular condensates to treat insulin resistance, diabetes progression

Ruchika Sharma24 March 2023 10:00 AM IST

Boston: Dewpoint Therapeutics has announced a research and development partnership with Novo Nordisk to identify drug candidates using Dewpoint's...

USFDA nod to JnJ Tremfya for Crohns disease

Johnson & Johnson to seek US Supreme Court review on unit's bankruptcy

Ruchika Sharma23 March 2023 3:15 PM IST

J&J maintains its consumer talc products are safe and confirmed through thousands of tests to be asbestos-free.

Manufacturing licence of Marion Biotech cancelled by UP authority over cough syrup adulteration

Ruchika Sharma23 March 2023 2:15 PM IST

Noida: The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according...

Lyka Labs promoters settle case with Sebi in Rs 3.07 lakh over alleged violation of disclosure lapses

Ruchika Sharma23 March 2023 1:15 PM IST

The order came after the applicants filed settlement applications for proposing to settle by neither "admitting nor denying the findings of fact and...

USFDA refuses to approve AbbVie Parkinson's disease therapy ABBV-951, seeks more information

Ruchika Sharma23 March 2023 12:15 PM IST

The US health regulator has not sought additional efficacy and safety trials, the company said, adding it plans to resubmit the marketing application...

Sun Pharma Told to Revise Delafloxacin Phase III Trial Protocol

Osteoarthritis candidate MM-II shows durable pain relief in global phase 2b study: Sun Pharma

Ruchika Sharma23 March 2023 11:26 AM IST

Osteoarthritis is one of the most common chronic health conditions and a leading cause of pain and disability among adults.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok